Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiation Therapy for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer

NCT01657617 is registered in ClinicalTrials.gov with Ronald McGarry as lead sponsor.

NCT NCT01657617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiation Therapy for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer
Lead sponsor
Ronald McGarry
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2007
Completion date
July 9, 2018
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer